The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_001323289.2(CDKL5):c.1768G>A (p.Glu590Lys)

CA10360416

680382 (ClinVar)

Gene: CDKL5
Condition: CDKL5 disorder
Inheritance Mode: X-linked inheritance
UUID: 05067df3-3a57-4067-95be-a1f6bd26509f
Approved on: 2023-03-17
Published on: 2023-03-31

HGVS expressions

NM_001323289.2:c.1768G>A
NM_001323289.2(CDKL5):c.1768G>A (p.Glu590Lys)
NC_000023.11:g.18604692G>A
CM000685.2:g.18604692G>A
NC_000023.10:g.18622812G>A
CM000685.1:g.18622812G>A
NC_000023.9:g.18532733G>A
NG_008475.1:g.184088G>A
ENST00000623535.2:c.1768G>A
ENST00000635828.1:c.1768G>A
ENST00000674046.1:c.1768G>A
ENST00000379989.6:c.1768G>A
ENST00000379996.7:c.1768G>A
ENST00000463994.4:c.1768G>A
ENST00000623535.1:n.1768G>A
NM_001037343.1:c.1768G>A
NM_003159.2:c.1768G>A
NM_001323289.1:c.1768G>A
NM_001037343.2:c.1768G>A
NM_003159.3:c.1768G>A

Benign

Met criteria codes 3
BP5_Strong BS2 BS1
Not Met criteria codes 3
BP4 PP3 PM1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Rett and Angelman-like Disorders VCEP
The allele frequency of the p.Glu590Lys variant in CDKL5 is 0.015% in Latino sub population in gnomAD, which is high enough to be classified as likely benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). Additionally, the p.Glu590Lys variant is observed in at least 14 unaffected individuals (internal database - GeneDx) (BS2) and at least 4 patients with an alternate molecular basis of disease (internal database - Invitae, internal database - GeneDx) (BP5_strong). In summary, the p.Glu590Lys variant in CDKL5 is classified as Benign for CDKL5-associated disorder based on the ACMG/AMP criteria (BS1, BS2, BP5_Strong).
Met criteria codes
BP5_Strong
The p.Glu590Lys variant is found in at least 4 patients with an alternate molecular basis of disease (internal database - Invitae, internal database - GeneDx) (BP5_Strong).
BS2
The p.Glu590Lys variant is observed in at least 2 unaffected individuals (internal database - GeneDx) (BS2).
BS1
The allele frequency of the p.Glu590Lys variant in CDKL5 is 0.015% in Latino sub population in gnomAD, which is high enough to be classified as likely benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1).
Not Met criteria codes
BP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.